← Insider buys
SYRS

Syros Pharmaceuticals, Inc. · Healthcare

Chief Medical Officer David Roth sold $29K of Syros Pharmaceuticals, Inc.

Sold$29,025
$3.95Price
7,348Shares
−100%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Mon, Jul 31. Filed Wed, Aug 2, 12:21 PM ET, during the session. Not investment advice.